Related references
Note: Only part of the references are listed.Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome
Alice Bonanni et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Rituximab in The Management of Pediatric Steroid-Resistant Nephrotic Syndrome: A Systematic Review
Manel Jellouli et al.
JOURNAL OF PEDIATRICS (2018)
Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study
N. Prasad et al.
INDIAN JOURNAL OF NEPHROLOGY (2018)
Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment
Shuichiro Fujinaga et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)
Repeated administrations of rituximab along with steroids and immunosuppressive agents in refractory steroid-resistant nephrotic syndrome
Shuichiro Fujinaga et al.
INDIAN PEDIATRICS (2017)
Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome
Shuichiro Fujinaga et al.
CLINICAL NEPHROLOGY (2016)
Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy
Kenji Ishikura et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2015)
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial
Pietro Ravani et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Rituximab-associated agranulocytosis in children with refractory idiopathic nephrotic syndrome: case series and review of literature
Koichi Kamei et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
Kazumoto Iijima et al.
LANCET (2014)
Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome
Koichi Kamei et al.
PEDIATRIC NEPHROLOGY (2014)
Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome
Shuichi Ito et al.
PEDIATRIC NEPHROLOGY (2013)
The uncertainty of rituximab and steroid dosing in refractory steroid-resistant nephrotic syndrome
Daishi Hirano et al.
CLINICAL NEPHROLOGY (2012)
Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
Alberto Magnasco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome: Multicentric Report
Ashima Gulati et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine
Shuichiro Fujinaga et al.
PEDIATRIC NEPHROLOGY (2010)
Rituximab for refractory focal segmental glomerulosclerosis
Makiko Nakayama et al.
PEDIATRIC NEPHROLOGY (2008)
Share Paper
